Suppr超能文献

促尿酸排泄药抑制大鼠肾刷状缘膜囊泡中的尿酸转运蛋白。

Uricosurics inhibit urate transporter in rat renal brush border membrane vesicles.

作者信息

Dan T, Koga H

机构信息

Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan.

出版信息

Eur J Pharmacol. 1990 Oct 23;187(3):303-12. doi: 10.1016/0014-2999(90)90357-c.

Abstract

It has been proposed that a urate-anion exchanger system in brush border membrane vesicles (BBMV), which mediates hydroxyl ion (OH-) gradient-dependent urate uptake, is the most likely route for the mediation of urate transport in the first step of urate reabsorption in the proximal tubules. Luminal drugs which inhibit urate reabsorption would inhibit the transport of urate into the cell by blocking the urate-anion exchanger. To confirm this hypothesis, we investigated the inhibitory effects of well-known uricosuric drugs on the OH-/urate exchange in BBMV. The rank order of potency was benzbromarone greater than tienilic acid greater than sulfinpyrazone greater than probenecid, which is consistent with clinical doses in man. AA-193 (5-chloro-7,8-dihydro-3-phenylfuro[2,3-g]-1,2-benzisoxazole-7-carb oxylic acid), an excellent candidate for a uricosuric, exerted the most potent inhibition on urate uptake (Ki = 0.12 microM). In contrast with that by stilbene disulfonates, the inhibition by AA-193 or benzbromarone was reversible.

摘要

有人提出,刷状缘膜囊泡(BBMV)中的尿酸盐 - 阴离子交换系统介导依赖于羟离子(OH-)梯度的尿酸盐摄取,这是近端小管中尿酸盐重吸收第一步中尿酸盐转运介导的最可能途径。抑制尿酸盐重吸收的管腔药物会通过阻断尿酸盐 - 阴离子交换器来抑制尿酸盐进入细胞。为了证实这一假设,我们研究了著名的促尿酸排泄药物对BBMV中OH-/尿酸盐交换的抑制作用。效力顺序为苯溴马隆大于替尼酸大于磺吡酮大于丙磺舒,这与人体临床剂量一致。AA - 193(5 - 氯 - 7,8 - 二氢 - 3 - 苯基呋喃并[2,3 - g] - 1,2 - 苯并异恶唑 - 7 - 羧酸)是一种优秀的促尿酸排泄药物候选物,对尿酸盐摄取具有最有效的抑制作用(Ki = 0.12 microM)。与二苯乙烯二磺酸盐不同,AA - 193或苯溴马隆的抑制作用是可逆的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验